{"id":"741ad8c1-c131-4c1b-8b46-4fb662788f7a","modelId":"5af9f040-fefc-4fb8-aed5-61a20cc7b17d","versionId":null,"locationId":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","operatorId":null,"ownerId":null,"slug":"neurolutions-ipsihand-germany-europe","status":"operational","firstSeen":null,"statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"unreviewed","sources":[],"notes":"Commercial product — available for purchase in this market.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-20T04:09:15.144Z","updatedAt":"2026-08-20T04:09:15.144Z","model":{"id":"5af9f040-fefc-4fb8-aed5-61a20cc7b17d","companyId":"c5677c1a-8c95-438d-9619-849950504010","modelName":"IpsiHand","slug":"neurolutions-ipsihand","description":"FDA-cleared non-invasive BCI for stroke rehabilitation. First FDA-cleared BCI for stroke recovery.","formFactor":"biometric","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/","title":"Stroke-recovery device using brain-computer interface receives FDA market authorization","sourceName":"Washington University School of Medicine"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[],"createdAt":"2026-08-08T22:32:37.106Z","updatedAt":"2026-08-09T03:57:34.330Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"c5677c1a-8c95-438d-9619-849950504010","name":"NeuroLutions","slug":"neurolutions","description":"NeuroLutions (now merged into Kandu, Inc.) developed the [IpsiHand](/models/ipsihand) System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.","status":null,"founded":2007,"hq":"St. Louis, Missouri, USA","hqLat":null,"hqLng":null,"hqGeocodedAt":null,"hqAddress":null,"hqPrecision":null,"website":"neurolutions.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/","title":"Stroke-recovery device using brain-computer interface receives FDA market authorization","sourceName":"Washington University School of Medicine"}],"keyFacts":[{"label":"FDA","value":"First FDA-cleared BCI for stroke rehab"},{"label":"Product","value":"IpsiHand"},{"label":"Type","value":"Non-invasive BCI"},{"label":"Parent","value":"Kandu Inc."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:36.733Z","updatedAt":"2026-08-08T22:39:09.284Z"}},"version":null,"location":{"id":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","name":"Germany, Europe","slug":"germany-europe","kind":"country","parentLocationId":null,"region":null,"lat":null,"lng":null,"reviewStatus":"unreviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-20T04:07:01.358Z","updatedAt":"2026-08-20T04:07:01.358Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/neurolutions-ipsihand-germany-europe","url":"https://registry.deploy.report/deployments/neurolutions-ipsihand-germany-europe","name":"IpsiHand at Germany, Europe","identifier":"741ad8c1-c131-4c1b-8b46-4fb662788f7a","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/germany-europe","name":"Germany, Europe"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/neurolutions","name":"NeuroLutions"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/neurolutions-ipsihand","name":"IpsiHand"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"unreviewed","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"biometric","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}